Notch3 is upregulated in ovarian cancer stem cells. Combination of cisplatin with GSI effectively eliminates CSCs and bulk tumors, thus sensitizes tumors to platinum therapy. This evidence concerns the gene NOTCH3 and ovarian cancer.